MENU

TOI Stock Oncology Institute (The) (TOI, $0.17) RSI Indicator left the oversold zone on November 26, 2024

A.I.dvisor
at Tickeron.com
Loading...
TOI - Oncology Institute (The)
RSI signal
Bullish Trend
Odds of UP Trend
Tickeron
RSI signal
Price: $0.1726
Daily change: +$0.0211 (+13.93%)
Daily volume: 8.7M
Capitalization: $13M
Industry: Medical/Nursing Services
This is a signal that TOI's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options. A.I.dvisor looked back and found 32 similar cases where TOI's RSI Indicator left the oversold zone, and in of them led to a successful outcome. Odds of Success:

TOI in -3.96% downward trend, declining for three consecutive days on December 18, 2024

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where TOI declined for three days, in of 284 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Aroon Indicator for TOI entered a downward trend on December 03, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where TOI's RSI Oscillator exited the oversold zone, of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 56 cases where TOI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on December 19, 2024. You may want to consider a long position or call options on TOI as a result. In of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for TOI just turned positive on December 03, 2024. Looking at past instances where TOI's MACD turned positive, the stock continued to rise in of 36 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where TOI advanced for three days, in of 207 cases, the price rose further within the following month. The odds of a continued upward trend are .

TOI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TOI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.033) is normal, around the industry mean (4.577). P/E Ratio (222.222) is within average values for comparable stocks, (71.885). TOI's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.595). TOI has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.026). P/S Ratio (0.355) is also within normal values, averaging (21.067).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TOI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

View a ticker or compare two or three
TOI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
N/A
Address
18000 Studebaker Road
Phone
+1 562 735-3226
Employees
800
Web
https://www.theoncologyinstitute.com